Flower

Abbott and YRG Care to study HIV and Hepatitis pattern in India

by The Welthi Bureau

Abbott and YRG Care to study HIV and Hepatitis pattern in India
 Image used for representational purpose only

Strengthening India's efforts in combating HIV and hepatitis viruses, Abbott has announced its partnership with Y.R. Gaitonde Centre for AIDS Research and Education (YRGCARE) to study the country's viral diversity to improve accuracy of diagnostic tests. Abbott will provide study protocol and diagnostic equipment and YRGCARE will help in screening and sequencing rich patient data from infected populations in India.

 

HIV and viral hepatitis are among the biggest public health threats in India today as they can produce many genotypes*, which keep combining to form recombinant strains or mutations making detection trickier. Therefore, understanding the distribution of genotypes and recombinants is critical to the development of diagnostic tests.

 

With more than 2.1 million people living with HIV, India has the third largest HIV incidence in the world with a large part co-infected with hepatitis C virus (HCV). People who inject drugs (PWID) and sex workers are identified as key affected populations for which the epidemic is growing. 

 

Speaking about the partnership Dr Sushil G Devare, Director of Diagnostics Research at Abbott said, "In the fight against HIV and viral hepatitis, we are pleased to collaborate with YRGCARE as they are pioneers of AIDS research and have extensive experience in understanding the HIV patient communities across the country. With sequence data generated under this partnership, Abbott endeavours to understand new viral mutations and variations of HIV and HCV leading to the development of newer tests and diagnostic kits to improve detection. We are confident that our joint efforts will offer unique insights into the genetic diversity of HIV and HCV including those that are found in higher risk groups like PWID."

 

Dr Sunil Suhas Solomon, Chairman, YRGCARE said, "We are excited to partner with Abbott to study emerging patterns of HIV and viral hepatitis in India. Drug using populations or PWIDs in India bear a disproportionate burden of HIV and HCV, and it's critical to understand the transmissions in this group. Sequencing data in these affected populations will help us conduct evolutionary nature of the viruses enabling optimal therapy options and treatment interventions to maximize impact." 

Established more than twenty years ago, Abbott's Global Surveillance Programme spans 40 countries across six continents, identifying and characterizing more than 5,000 virus strains, ensuring that current diagnostic tests to detect a wide range of HIV and hepatitis viruses and determine the need for newer tests to stay ahead of evolving viruses.

 

India is the latest addition to Abbott's recent surveillance efforts in Asia-Pacific to provide new insights on the strains and transmission of these viruses specific to India. Abbott is the only diagnostic test manufacturer with such a unique, longstanding and large-scale virus Surveillance Programme. Besides India, Abbott has collaborated with partners in China, Australia, Vietnam, Laos and Pakistan to ensure its Surveillance Programme covers key regions. In addition, Abbott works with commercial partners in Nepal the Philippines as well as the Red Cross in Thailand to gain access to circulating strains of HIV and hepatitis viruses, thus ensuring a real representation of the prevalent infections.


 Disclaimer: Welthi.com does not guarantee any specific results as a result of the procedures mentioned here, and the results may vary from person to person. Read more
Cochlear Implants to Aid Children With Hearing Difficulties - Surgery to help in improving speech and language skills among the young  Hyderabad, 14th October 2018: Hearing is a one of the most important sense that also plays a very crucial role in verbal

Cochlear Implants to Aid Children With Hearing ...

Surgery to help in improving speech and language s...
“Maxi-O Lipi Flow” world’s best device for dry eyes treatment launched in MaxiVision Eye Hospitals

“Maxi-O Lipi Flow” world’s best device for ...

Now freedom from dry eyes is just a step away in H...
Different bodies, one message

Different bodies, one message

Aishwarya Sharma, a fashion activist and founder a...
Pediatric Liver transplant in Gleneagles Global Hospitals

Pediatric Liver transplant in Gleneagles Global ...

The Gleneagles Global Hospitals Hyderabad is delig...
Child Obesity: A burgeoning barrier to healthy living

Child Obesity: A burgeoning barrier to healthy ...

The World Obesity Day is celebrated on 11th Octobe...
Get off your smart gadgets

Get off your smart gadgets

The repetitive motions of texting and typing can l...
Hyderabad Doctors successfully perform Asia's First Transcatheter Tricuspid Valve Replacement procedure

Hyderabad Doctors successfully perform Asia's ...

Only 40 such surgeries reported around the world...
SuVitas Launches Bangalore’s First Dedicated Transition Care Facility

SuVitas Launches Bangalore’s First Dedicated ...

Catering to a need for post critical care that has...
Itermittent Fasting: The How s and Why's

Itermittent Fasting: The How s and Why's

Intermittent Fasting is the latest global fitness ...
Our responsibility to our emotions

Our responsibility to our emotions

In this world, there are all kinds of people. Some...
Stop drowsing while driving

Stop drowsing while driving

A long spell of work or drive can lead to physical...
Eyes show you the world

Eyes show you the world

With increasing rate of air pollution, the ways it...